IL-1 Inhibition in Early TNBC

Clinical trial NCT06710197 · WITHDRAWN

Trial details

NCT number: NCT06710197
Sponsor: University Health Network, Toronto
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Early Stage Triple Negative ER Low Breast Cancer

Start date: 2025-03-05
Primary completion: 2026-02-12
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.